| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| TFR-H82E5 | Human | Biotinylated Human Transferrin R / CD71 Protein, His,Avitag™ (MALS verified) |  |
|
|
| TFR-C524a | Cynomolgus | Cynomolgus Transferrin R / CD71 Protein, His Tag |  |
|
|
| TFR-H8243 | Human | Biotinylated Human Transferrin R / CD71 Protein, His Tag, ultra sensitivity (primary amine labeling) |  |
|
|
| CD1-H5243 | Human | Human Transferrin R / CD71 Protein, His Tag |  |
|
|
Immobilized Human Transferrin, His Tag (Cat. No. TRN-H4229) at 5 μg/mL (100 μL/well) can bind Cynomolgus Transferrin R, His Tag (Cat. No. TFR-C524a) with a linear range of 0.2-6 ng/mL (QC tested).
The purity of Biotinylated Human Transferrin R, His,Avitag(Cat. No. TFR-H82E5) was more than 90% and the molecular weight of this protein is around 160-180 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| SGT-94 | SGT-94; SGT-RB94 | Phase Ⅰ | SynerGene Therapeutics | Solid tumours | Details |
| CX-2029 | CX-2029 | Phase Ⅱ | CytomX Therapeutics, Abbvie | Diffuse large B cell lymphoma, Solid tumours | Details |
| Monoclonal antibody 42/6 | Phase Ⅰ | Nonindustrial source | Cancer | Details |
This web search service is supported by Google Inc.
A-Z